Related Experiment Video
Updated: Jul 5, 2026

Isolation of Group 2 Innate Lymphoid Cells from Mouse Nasal Mucosa to Detect the Expression of CD226
Published on: May 10, 2022
Interleukin-2 immediate type hypersensitivity?
Peri Caucig1, Susanne Lescau, Jürgen Knop
1Department of Dermatology, Johannes Gutenberg University, Mainz, Germany.
Two patients experienced hypersensitivity-like reactions to recombinant interleukin-2 (IL-2) immunotherapy for melanoma. Investigations revealed IgE-independent mast cell degranulation, suggesting a pseudoallergic response to IL-2.
Area of Science:
- Immunology
- Oncology
- Dermatology
Background:
- Metastatic malignant melanoma is a serious cancer.
- Recombinant interleukin-2 (IL-2) is a form of immunotherapy used to treat melanoma.
- Immediate type hypersensitivity reactions can occur during cancer treatment.
Observation:
- Two patients receiving IL-2 immunotherapy for metastatic melanoma developed symptoms resembling immediate hypersensitivity.
- These symptoms included positive skin prick tests to IL-2 and enhanced basophil degranulation in vitro.
- Patients responded to antihistamine treatment.
Findings:
- Laboratory investigations indicated an IgE-independent mechanism for mast cell degranulation.
- The findings suggest a pseudoallergic reaction to IL-2 rather than a true IgE-mediated allergy.
- Mast cell activation was directly triggered by IL-2.
Implications:
- This research highlights a potential pseudoallergic pathway for IL-2-induced hypersensitivity.
- Understanding this mechanism is crucial for managing adverse reactions to IL-2 immunotherapy.
- Further research may lead to improved patient management strategies for IL-2 therapy.
Related Concept Videos
Hypersensitivities
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions
Hypersensitivity Reactions: Immune-Complex Reactions
Allergic Drug Reactions
Drug Toxicity: Allergic Reactions
Hypersensitivity Reactions: Cytolytic Reactions

